Vascular disease among hospitalized multiple sclerosis patients

Neuroepidemiology

Volumn 30, Issue 4, 2008, Pages 234-238

  Allen, Norrina B ^a,c   Lichtman, Judith H ^a   Cohen, Hillel W ^b   Fang, Jing ^b   Brass, Lawrence M ^a   Alderman, Michael H ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Ischemic stroke; Multiple sclerosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; GENDER; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INSURANCE; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREVALENCE; RACE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; VASCULAR DISEASES;

EID: 45749135898     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128103     Document Type: Article

References (13)

1. Toncev G, Milicic B, Toncev S, Samardzic G: Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol 2002;9:221-226.
2. Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D: Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 2006;108:527-531.
3. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-1190.
4. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-2410.
5. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM: Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006:37:1503-1507.
6. Fleming ST, Blake RL Jr: Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol 1994;47:1127-1132.
7. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005:45:28-33.
8. Chu NF, Wang DJ, Liou SH, Shieh SM: Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 2000;16:13-17.
9. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-362.
10. Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998;8:250-261.
11. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF: Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005;43:480-485.
12. Fisher ES, Whaley FS, Krushat WM, Malenka DJ, Fleming C, Baron JA, Hsia DC: The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health 1992;82:243-248.
13. Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998;29:1602-1604.